Journal of Lipid Research, Vol 32, 71-78, Copyright © 1991 by Lipid Research, Inc.

ARTICLES

Effects of lovastatin on biliary lipid secretion and bile acid metabolism in humans

JC Mitchell, GM Logan, BG Stone and WC Duane
Department of Medicine, Veterans Administration Medical Center, Minneapolis, MN.

Lovastatin, an inhibitor of HMG-CoA reductase, lowers cholesterol saturation of bile. To determine the mechanism of this effect and further define the role of cholesterol synthesis in regulation of biliary lipid metabolism, we studied ten human volunteers in a control period and again after 5-6 weeks on lovastatin, 40 mg b.i.d. Mean sterol production from acetate in mononuclear leukocytes fell from 1.18 to 0.84 pmol/min per 10(6) cells on lovastatin (P less than 0.02). Concomitantly there was reduction in mean biliary secretion of cholesterol from 143 to 96 mumol/h (P less than 0.02). On lovastatin, mean pool size of bile acids by the Lindstedt method fell from 3193 to 2917 mumol (one-sided P = 0.05) and mean pool size by the one-sample method fell from 5158 to 4091 mumol (P less than 0.002). Lovastatin had no effect on mean fractional turnover rate of either cholic acid (0.77 vs. 0.74 day-1) or chenodeoxycholic acid (0.51 vs. 0.54 day-1). Mean total bile acid synthesis was lower on lovastatin (1443 vs. 1240 mumol/day), but the difference did not quite achieve statistical significance. In humans, inhibition of cholesterol synthesis by lovastatin lowers biliary cholesterol saturation by reducing cholesterol secretion into bile. Bile acid pool size, and perhaps bile acid synthesis, are also reduced by this inhibition.
CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				C. M. Ballantyne, J. Houri, A. Notarbartolo, L. Melani, L. J. Lipka, R. Suresh, S. Sun, A. P. LeBeaut, P. T. Sager, and E. P. Veltri Effect of Ezetimibe Coadministered With Atorvastatin in 628 Patients With Primary Hypercholesterolemia: A Prospective, Randomized, Double-Blind Trial Circulation, May 20, 2003; 107(19): 2409 - 2415. [Abstract] [Full Text] [PDF]

				F Lanzarotto, B Panarotto, R Sorbara, M Panteghini, F Pagani, S Sosta, and A Lanzini Effect of long term simvastatin administration as an adjunct to ursodeoxycholic acid: evidence for a synergistic effect on biliary bile acid composition but not on serum lipids in humans Gut, April 1, 1999; 44(4): 552 - 556. [Abstract] [Full Text] [PDF]

				D. Hurnanen, H. M. Chan, and S. Kubow The Protective Effect of Metallothionein Against Lipid Peroxidation Caused by Retinoic Acid in Human Breast Cancer Cells J. Pharmacol. Exp. Ther., December 1, 1997; 283(3): 1520 - 1528. [Abstract] [Full Text]